Skip to main content
. Author manuscript; available in PMC: 2017 May 12.
Published in final edited form as: Am J Nephrol. 2016 May 12;43(5):325–333. doi: 10.1159/000445757

Appendix Table 7.

Association of eGFR and All-cause Mortality by Quartile of eGFR

Relative Hazard (95% Confidence Interval)
Estimating Equation
Category (mL/min/1.73m2)
Age Adjusted Incidence Rate per
1,000 Person Years (95% CI)
Unadjusted Base Model* Final Model**
CKD-EPIcr, cysc
 Q4: ≥83 24.74 (19.57, 29.92) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3:71 to <83 29.36 (23.91, 34.81) 1.41 (1.10, 1.81) 1.13 (0.88, 1.45) 1.12 (0.87, 1.44)
 Q2:58 to <71 35.97 (30.14, 41.80) 1.94 (1.54, 2.45) 1.32 (1.03, 1.68) 1.29 (1.01, 1.64)
 Q1:<58 48.03 (41.57, 54.50) 3.33 (2.68, 4.15) 1.78 (1.40, 2.26) 1.61 (1.26, 2.05)
 p-trend <0.001 <0.001 <0.001
BIS2
 Q4: ≥71 27.37 (20.38, 34.35) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3:63 to <71 28.29 (23.58, 33.01) 1.50 (1.17, 1.93) 1.19 (0.92, 1.53) 1.19 (0.92, 1.54)
 Q2:53 to <63 33.44 (27.82, 39.07) 1.91 (1.50, 2.43) 1.28 (1.00, 1.64) 1.25 (0.98, 1.61)
 Q1:<53 50.76 (43.72, 57.79) 3.78 (3.03, 4.72) 1.90 (1.48, 2.43) 1.71 (1.33, 2.20)
 p-trend <0.001 <0.001 <0.001
CKD-EPIcr
 Q4: ≥82 33.40 (25.94, 40.85) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3: 73 to <82 30.81 (25.63, 36.00) 1.23 (0.98, 1.55) 0.86 (0.68, 1.09) 0.84 (0.67, 1.07)
 Q2:61 to <73 32.39 (27.63, 37.14) 1.43 (1.15, 1.79) 1.16 (0.92, 1.45) 0.92 (0.73, 1.15)
 Q1:<61 40.86 (35.42, 46.30) 2.20 (1.79, 2.71) 1.25 (0.82, 1.89) 1.15 (0.75, 1.76)
 p-trend <0.001 0.047 0.36
CKD-EPIcysc
 Q4:≥82 26.99 (20.47, 33.52) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3:67 to <82 29.37 (23.82, 34.91) 1.39 (1.08, 1.79) 1.15 (0.89, 1.48) 1.14 (0.88, 1.47)
 Q2:53 to <67 34.58 (28.90, 40.26) 1.94 (1.53, 2.47) 1.31 (1.02, 1.68) 1.29 (1.00, 1.65)
 Q1:<53 52.51 (45.62, 59.39) 3.76 (3.01, 4.68) 2.04 (1.60, 2.60) 1.83 (1.43, 2.35)
 p-trend <0.001 <0.001 <0.001

Abbreviations: eGFR, estimated glomerular filtration rate; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; cr, creatinine; cysc, cystatin c; BIS, Berlin Initiative Study

*

adjusted for age, race, and body mass index

**

adjusted for age, race, body mass index, hypertension, diabetes mellitus, congestive heart failure, coronary heart disease, and stroke